An ALBI- and Ascites-Based Model to Predict Survival for BCLC Stage B Hepatocellular Carcinoma

Figure 2

(a) Kaplan–Meier curve of overall survival in patients from the group of high ALBI score and no ascites and group of low ALBI score and ascites. Kaplan–Meier curve of overall survival in patients from the low-risk (low ALBI score and no ascites), high risk (high ALBI score and ascites) and the rest patients (the middle risk).

(a)

(b)